Species dfferences in the inhibition of pentobarbital metabolism by empenthrin

Environmental Toxicology and Pharmacology

Volumn 2, Issue 4, 1996, Pages 331-337

  Tsuji, Ryozo ^a   Isobe, Naohiko ^a   Kurita, Yasuyuki ^a   Hanai, Koji ^a   Yabusaki, Yoshiyasu ^a   Kawasaki, Hajime ^a  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

Author keywords

Empenthrin; Pentobarbital; Species difference

Indexed keywords

CYTOCHROME P450; EMPENTHRIN; PENTOBARBITAL; PYRETHROID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; COMPUTER SIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; ENZYME BINDING; GUINEA PIG; HAMSTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; RAT; SLEEP TIME; SPECIES DIFFERENCE; YEAST;

EID: 0030596143     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(96)00066-X     Document Type: Article

References (25)

1. Allen, F.H., O. Kennard and R. Taylor, 1983, Systematic analysis of structural data as a research technique in organic chemistry, Acc. Chem. Res. 16, 146.
2. Andre, P., J. Desuites, R. Simont and J.C. Evreux, 1984, Reappraisal of the barbiturate sleeping time in mice as predictive tool for the detection of liver enzymes inhibiting drugs, Methods Find. Exp. Clin. Pharmacol. 6, 695.
3. Brian, W.R., P.K. Srivastava, D.R. Umbenhauer, R.S. Lloyd and P.P. Guengerich, 1989, Expression of human liver cytochrome P450 protein with tolubutamide hydroxylase activity in Saccharomyces cerevisiae, Biochemistry 28, 4993.
4. Brodie, B.B., J.J. Burns, L.C. Mark, P.A. Lief, E. Bernstein and E.M. Papper, 1953, The fate of pentobarbital in man and dog and a method for its estimation in biological material, J. Pharmacol. Exp. Ther. 109, 26.
5. Cooper, J.R. and B.B. Brodie, 1957, Enzymatic oxidation of pentobarbital and thiopental, J. Pharmacol. Exp. Ther. 120, 75.
6. Dewar, M.J.S., E.G. Zoebisch, E.F. Healy and J.J.P. Stewart, 1985, AM1: A new general purpose quantum mechanical molecular model, J. Am. Chem. Soc. 107, 3902.
7. Freudenthal, R.I. and F.I. Carroll, 1973, Metabolism of certain commonly used barbiturates, Drug Metab. Rev. 2, 265.
8. Guengerich, F.P., L.M. Distlerath, P.E.B. Reilly, T. Wolff, T. Shimada, D.R. Umbenhauer and M.V. Martin, 1986, Himan-liver cytochrome P-450 involved in polymorphisms of drug oxidation, Xenobiotica 16, 367.
9. Imaoka, S., T. Yamada, T. Hiroi, K. Hayashi, T. Sakaki, Y. Yabusaki and Y. Funae, 1996, Multiple form of human P450 expressed in Saccharomyces cerevisiae: Systematic characterization and comparison with those of the rat, Biochem. Pharmacol. 51, 1041.
10. Ishikawa, M., I. Suzuki, M. Ozaki, Y. Takayanagi and K. Sasaki, 1991, Interaction of doxapram and pentobarbital in mice, Pharmacol. Toxicol. 69, 276.
11. Isobe, N., T. Suzuki, J. Nishikawa, H. Kaneko, I. Nakatsuka and A. Yoshitake, 1992, Metabolism of empenthrin isomers in rats, J. Pesticide Sci. 17, 27.
12. Kaneko, H., S. Kawaguchi, Y. Misaki, Y. Koyama, A. Nakayama, H. Kawasaki, A. Hirohashi, A. Yoshitake and H. Yamada, 1992, Mammalian toxicity of empenthrin (Vaporthrin®, S-2852F), J. Toxicol. Sci. 17, 313.
13. Koymans, L., N. Vermeulen, S. Acker, J. Koppele, J. Heykants, K. Lavrijsen, W. Meuldermans and G. Kelder, 1992, A predictive model for substrates of cytochrome P450-debrisoquine (2D6), Chem. Res. Toxicol. 5, 211.
14. Maynert, E.W., 1965, The alcoholic metabolites of pentobarbital and amobarbital in man, J. Parmacol. Exp. Ther. 150, 118.
15. Meyer, U.A., J. Gut, T. Kronbach, C. Skoda, U.T. Meier and T. Catin, 1986, The molecurlar mechanisms of two common polymorphisms of drug oxidation - Evidence for functional changes in cytochrome P-450 isozymes catalyzing bufuralol and mephenytoin oxidation. Xenobiotica 16, 449.
16. Miyamoto, J., H. Kaneko, R. Tsuji and Y. Okuno, 1995, Pyrethroids, nerve poisons: how their risks to human health should be assessed, Tox. Lett. 82/83, 933.
17. Nebert, D.W., D.R. Nelson, M.J. Coon, R.W. Estabrook, R. Feyereisen, Y. Fujii-Kuriyama, F.J. Gonzalez, P.P. Guengerich, I.C. Gunsalus, E.F. Johnson, J.C. Loper, R. Sato, M.R. Waterman and D.J. Waxman, 1991, The P-450 superfamilies: Update on new sequences, gene mapping, and recommended nomenclature, DNA Cell Biol. 10, 1.
18. Shimada, T., M. Iwasaki, M.V. Martin and P.P. Guengrich, 1989a, Human liver microsomal cytochrome P-450 enzymes involved in bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002, Cancer Res. 49, 3218.
19. Shimada, T., M.V. Martin, D. Pruess-Schwartz, L.J. Marnett and F.P. Guengrich, 1989b, Role of individual human cytochrome P-450 enzyme in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene and other dihydrodiol derivatives of polycyclic sromatic hydrocarbons, Cancer Res. 49, 6304.
20. Slater, B., A. McCormack, A. Avdeef and J.E.A. Comer, 1994, pH-Metric logP.4, Comparison of partition coefficients determined by HPLC and potentiometric methods to literature values, J. Pharm. Sci. 83, 1280.
21. Smit, P.H. and J.A. Kanters, 1974, Crystal and molecular structure of 5-ethyl-5-(1, 3-dimethylbutyl) barbituric acid (α-methylamobarbital), Acta Crystallogr. Sect. B 30, 784.
22. Smith, P.K., R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Greke, B.J. Olson and D.C. Klenk, 1985, Measurement of protein using bicinchoninic acid, Anal. Biochem. 150, 76.
23. Tsuji, R., N. Isobe and H. Kawasaki, 1996a, Effect of pyrethroids on pentobarbital-induced sleeping time in relation to the chemical structure, Toxicology 106, 131.
24. Tsuji, R., N. Isobe and H. Kawasaki, 1996b, Mechanism of prolongation of pentobarbital-induced sleeping time by empenthrin in mice, Toxicology 108, 185.
25. Wolff, T., L.M. Distlerath, M.T. Worrthington, J.D. Groopman, G.J. Hammons, F.F. Kadlubar, R.A. Prough, M.V. Martin and F.P. Guengerich, 1986, Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhiition and chemical modeling, Cancer Res. 45, 2116.